INAB- In8bio, Inc.

Name: In8bio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

In8bio, Inc. (INAB) has 7 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. INAB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Fairbairn Emily	724.6K	$1.14M	-
CEO	Ho William Tai-Wei	206.0K	$325.5K	-
?	Brandt Peter C.	95.2K	$150.4K	-
COO	Rochlin Kate	80.0K	$126.4K	-
CFO	McCall Patrick	75.0K	$118.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 17, 2022	Fletcher Aaron G.L.55	Director, 10% Owner	Buy	50,000	$1.93	$96,500.00	+1.1%	-20.2%	-42.4%
Aug 16, 2022	Fletcher Aaron G.L.55	Director, 10% Owner	Buy	1,773,684	$1.90	$3,369,999.60	+69.3%	-19.6%	-37.0%
Aug 16, 2022	Fairbairn Emily	Director, 10% Owner	Buy	789,473	$1.90	$1,499,998.70	+23.8%	-19.6%	-37.0%
Aug 16, 2022	Ho William Tai-Wei	President, CEO And CFO	Buy	26,315	$1.90	$49,998.50	+1.1%	-19.6%	-37.0%
Aug 16, 2022	Rochlin Kate	Chief Operating Officer	Buy	5,263	$1.90	$9,999.70	New	-19.6%	-37.0%
Aug 16, 2022	McCall Patrick	Chief Financial Officer	Buy	5,263	$1.90	$9,999.70	New	-19.6%	-37.0%
Aug 16, 2022	Goswami Trishna	Chief Medical Officer	Buy	2,631	$1.90	$4,998.90	New	-19.6%	-37.0%
Aug 16, 2022	Lamb Lawrence	EVP And CSO	Buy	526	$1.90	$999.40	+0.5%	-19.6%	-37.0%
Aug 16, 2022	Kreis Leslie W.51	Director, 10% Owner	Buy	1,773,684	$1.90	$3,369,999.60	+69.3%	-19.6%	-37.0%
Aug 16, 2022	Brandt Peter C.	Director	Buy	105,263	$1.90	$199,999.70	+136.3%	-19.6%	-37.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC